177 related articles for article (PubMed ID: 8394915)
1. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
[TBL] [Abstract][Full Text] [Related]
2. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
Picker MJ; Craft RM; Negus SS; Powell KR; Mattox SR; Jones SR; Hargrove BK; Dykstra LA
J Pharmacol Exp Ther; 1992 Nov; 263(2):668-81. PubMed ID: 1331411
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
5. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
Picker MJ; Cook CD
Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
7. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
Picker MJ
J Pharmacol Exp Ther; 1994 Mar; 268(3):1190-8. PubMed ID: 8138931
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
Picker MJ
Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
[TBL] [Abstract][Full Text] [Related]
10. Examination of the kappa agonist and antagonist properties of opioids in the rat drug discrimination procedure: influence of training dose and intrinsic efficacy.
Smith MA; Picker MJ
Behav Pharmacol; 1995 Nov; 6(7):703-717. PubMed ID: 11224373
[TBL] [Abstract][Full Text] [Related]
11. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Morgan D; Picker MJ
Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
[TBL] [Abstract][Full Text] [Related]
12. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
Walker EA; Picker MJ; Granger A; Dykstra LA
J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
[TBL] [Abstract][Full Text] [Related]
13. Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor.
Morgan D; Picker MJ
Behav Pharmacol; 1996 May; 7(3):261-284. PubMed ID: 11224419
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor.
Morgan D; Cook CD; Picker MJ
J Pharmacol Exp Ther; 1999 May; 289(2):965-75. PubMed ID: 10215676
[TBL] [Abstract][Full Text] [Related]
15. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
Barrett AC; Smith ES; Picker MJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
Picker M; Dykstra LA
J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
[TBL] [Abstract][Full Text] [Related]
17. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
Colpaert FC; Janssen PA
J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
[TBL] [Abstract][Full Text] [Related]
18. Dietary cadmium exposure alters characteristics of training, substitution, and tolerance when morphine is used as a discriminative stimulus.
Nation JR; Miller DK; Bratton GR
Neurotoxicology; 2000 Aug; 21(4):553-67. PubMed ID: 11022863
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Picker MJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids.
Young AM; Masaki MA; Geula C
J Pharmacol Exp Ther; 1992 Apr; 261(1):246-57. PubMed ID: 1560372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
